Researchers Develop Microcapsules for Oral Delivery of Cell-Free Protein Production Systems
Researchers developed chitosan-coated alginate microcapsules capable of encapsulating cell-free gene expression (CFE) lysates and protecting protein cargo from degradation in simulated and actual gastrointestinal environments. The study demonstrated that CFE lysates could produce functional proteins within alginate matrices, though direct chitosan contact inhibited protein synthesis, and that the capsules released cargo in intestine-like conditions without inducing gut inflammation in mice. This work could advance oral delivery of protein therapeutics, which has long been hindered by the harsh proteolytic conditions of the GI tract.
A study posted to bioRxiv describes the development and testing of chitosan-coated alginate (Alg/Cht) microcapsules as a platform for orally delivering protein therapeutics produced via cell-free gene expression (CFE). CFE systems allow rapid, flexible, on-demand protein production outside of living cells, and combining them with protective polymer encapsulation could address a major challenge in oral drug delivery: the degradation of proteins by digestive enzymes. The researchers showed that CFE lysates successfully produced functional mCherry fluorescent protein in the presence of alginate, though direct contact with chitosan inhibited synthesis, suggesting the layered capsule architecture is important for preserving CFE activity. Alg/Cht microcapsules protected both encapsulated mCherry protein and CFE lysates from degradation in simulated human gastric fluids and mouse gastric extracts, and released cargo under simulated intestinal conditions. In mouse oral gavage experiments, none of the individual CFE or encapsulation components triggered gastrointestinal inflammation, and fluorescent bead cargo showed delayed release in the intestines, consistent with controlled delivery behavior. The authors conclude that CFE lysate-loaded Alg/Cht formulations represent a promising, safe, and flexible approach to producing and delivering protein therapeutics to the GI tract, though further in vivo validation will be needed.
What's missing
As a preprint, this study has not yet undergone peer review. Key limitations include the use of mCherry as a model protein rather than a therapeutically relevant protein, and the absence of pharmacokinetic or efficacy data demonstrating that encapsulated therapeutic proteins could reach systemic circulation or target tissues at functional doses. The mechanism by which chitosan inhibits CFE protein synthesis is not fully characterized, and long-term stability of CFE lysates within the capsules was not assessed.
What different sources said
- bioRxivCenter
Incorporation of active cell-free expression lysates in chitosan coated alginate microcapsules
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.